The pituitary gland has been termed the 'master gland' because of the
myriad of hormones that emanate from it that are vital for normal home
ostasis as well as growth and development, Primary tumors of this regi
on are frequent and account for up to 10% of intracranial tumors, Pitu
itary tumors are monoclonal in origin, and may arise from any of the d
ifferent cell types of the pituitary gland, Hence, these tumors may be
manifest by their hormonal secretions, This may lead to profound and
striking physiological changes attributable, for example, to prolactin
, growth hormone, or ACTH excess, The central location of the pituitar
y gland also leads to characteristic compressive symptoms. This review
,will explore the clinical presentations of growth hormone, ACTH, and
prolactin secreting tumors as well as the non-secreting pituitary tumo
rs, Advances in neuroimaging and neuropharmacology have resulted in ch
anges in our treatment of these tumors, Treatment modalities including
surgical, medical, and radiation therapy will be addressed, The treat
ment of choice is dictated by the type of tumor and the nature of the
excessive hormonal expression, Outcomes and efficacy of treatment are
discussed, (C) 1997 Elsevier Science Ltd.